ABSTRACT
Genetic testing is not currently part of the treatment algorithm for prostate cancer. But could DNA-repair defects influence the response to prostate cancer treatment? New research findings are summarized in this new Quick Take video.
See the NEJM article, "DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer":
http://www.nejm.org/doi/full/10.1056/...